Drug Profile
TyOraSs vaccine - Protein Potential
Alternative Names: Shigella/Typhoid vaccine - Protein PotentialLatest Information Update: 28 Apr 2019
Price :
$50
*
At a glance
- Originator Protein Potential
- Class Bacterial vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Shigella infections; Typhoid
Most Recent Events
- 28 Apr 2019 No recent reports of development identified for preclinical development in Shigella-infections(Prevention) in USA (PO, Fast dissolve)
- 28 Apr 2019 No recent reports of development identified for preclinical development in Typhoid(Prevention) in USA (PO, Fast dissolve)
- 15 Jun 2017 Immunogenicity data from a preclinical trial in Shigella infections released by Protein Potential